Pfizer-BioNTech vaccine offers protection against new Covid-19 strain
- 3 years ago
A preliminary study has revealed that Pfizer-BioNTech vaccine offers protection against the new strain of SARS-CoV-2, which causes novel coronavirus disease (Covid-19), according to UAE doctors.
The trend would help contain the viral outbreak, they hoped.
Pfizer-BioNTech’s Covid-19 vaccine appeared to work against a key mutation in the highly transmissible new variant of the virus and recently found in the United Kingdom (UK) and South Africa, according to the study.
The study, which is yet to be peer reviewed, is conducted by Pfizer and scientists from the University of Texas Medical Branch, US. It indicated the vaccine was apparently effective in neutralising the virus with the N501Y mutation of the spike protein.
The trend would help contain the viral outbreak, they hoped.
Pfizer-BioNTech’s Covid-19 vaccine appeared to work against a key mutation in the highly transmissible new variant of the virus and recently found in the United Kingdom (UK) and South Africa, according to the study.
The study, which is yet to be peer reviewed, is conducted by Pfizer and scientists from the University of Texas Medical Branch, US. It indicated the vaccine was apparently effective in neutralising the virus with the N501Y mutation of the spike protein.